Global Neurostimulation Devices Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027

Neurostimulation Devices Market Overview

The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global neurostimulation devices market report has been segmented on the basis of product, application, and region.

Request Covid - 19 Impact

Neurostimulation devices are used for the treatment of long-lasting chronic pain. It is an electric system that works with the help of a battery that is placed under the skin. Also, Lead (medically used wire) is placed inside the body either in the spine at back, the neck, or on the specific nerves.

The device sends small electric beats; these electric beats block the pain message from reaching the brain. Neurostimulation does not remove the source of pain but changes the feeling of pain.

Technological advancements in the treatment of neurological disorder such as the introduction of neurostimulation devices that help to reduce chronic pain with mild electric beats is a major factor driving the growth of the global neurostimulation devices market. In addition, increasing government expenditure on the healthcare sector, increasing incidences of neurological disorders and increasing preference by the geriatric population for minimally invasive procedures that have early recovery time are other factors expected to boost the growth of the global neurostimulation devices market.

Moreover, various advantages of neurostimulation devices such as less need for oral medications, the ability to sit walk, and stand for a long period of time, etc. are expected to support the growth of the global neurostimulation devices market.

However, side effects associated with the implant neurostimulation devices such as damage to nerves, infection at the implant site, etc. are a major factor hampering the growth go the global neurostimulation devices market.

Technological advancements such as the development of devices that are compatible with magnetic resonance and other magnetic and electronic devices are expected to present new opportunities in terms of revenue to players operating in the market.

The North American market is expected to dominate the global neurostimulation devices market with a higher market share when compared to other regional markets and is expected to continue its dominance during the forecast period. This can be attributed to the increasing number of people suffering from neurological disorders and increasing use of neurostimulation devices by the geriatric population, and the presence of prominent market players operating in this region.

The Europe market accounts for the second-largest revenue share in the global neurostimulation devices market followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to witness the fastest growth in terms of revenue, owing to increasing government expenditure on the healthcare sector and preference for minimally invasive techniques by patients in emerging economies in this region.

Global Neurostimulation Devices Market Segmentation:

By Product:

• Spinal Cord Stimulator
• Deep Brain Stimulator
• Sacral Nerve Stimulator
• Vagus Nerve Stimulator
• Gastric Electric Stimulator

By Application:

• Pain Management
• Epilepsy
• Essential Tremor
• Urinary and Fecal Incontinence
• Others (Depression, Dystonia, Gastroparesis, Parkinson's Disease)

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa